Cereius, Inc. Announces $6.75 Million Financing Proceeds to Advance...

Cereius, Inc., a biotechnology company developing novel approaches to treat solid tumor brain metastases, announced today that it has closed a $6.75 million financing.(PRWeb July 25, 2018)Read the full story at https://www.prweb.com/releases/cereius_inc_announces_6_75_million_financing_proceeds_to_advance_novel_therapies_for_treating_solid_tumor_brain_metastasis/prweb15645468.htm
Source: PRWeb: Medical Pharmaceuticals - Category: Pharmaceuticals Source Type: news